...
首页> 外文期刊>BMC Ophthalmology >Detection of autoantibodies against heat shock proteins and collapsin response mediator proteins in autoimmune retinopathy
【24h】

Detection of autoantibodies against heat shock proteins and collapsin response mediator proteins in autoimmune retinopathy

机译:自身免疫性视网膜病中抗热休克蛋白和胶原蛋白反应介质蛋白的自身抗体的检测

获取原文

摘要

Background Autoimmune retinopathy (AR) and Cancer-Associated Retinopathy (CAR) are associated with a diverse repertoire of anti-retinal autoantibodies (AAbs) but not all antigenic targets have been characterized. Identification of new AAbs may help with clinical diagnosis and prognosis of retinal dysfunction in AR. The goal was to identify frequently targeted retinal autoantigens within the 60-70-kDa molecular weight range. Methods Human retinal proteins were separated by SDS-PAGE and 2D gel electrophoresis (2-DE) and sera from AR patients with and without cancer were used to identify immunoreactive proteins by Western blotting. Proteins were identified following separation by electrophoresis, Coomassie staining using in-gel trypsin digestion and mass spectrometric analysis. Circulating serum hsp60 and anti-hsp60 antibody levels were determined by quantitative ELISA. Results Retrospective evaluation of 819 patients with anti-retinal AAbs showed that 29% patients had AAbs targeted proteins between 60-70-kDa. Shotgun mass spectrometry of human retinal proteins present in 1D-gel found 66 species within this range. To identify the immunoreactive proteins, we performed Western blots of 2-DE gels and showed a group of heat shock proteins (hsps), including hsp60 and CRMP proteins that were frequently recognized by AR patient AAbs, irrespective of cancer status. These results were validated by immunostaining of purified hsp60 and CRMP2 proteins. ELISA results revealed that patients with AR and CAR had significantly increased levels of serum anti-hsp60 antibodies compared to control healthy subjects (p? Conclusions Different anti-retinal antibodies frequently co-exist in a single patient, creating antibody-arrays related to the syndrome. Hsps and CRMP-2 are newly identified autoantigens in AR. A frequent co-association of anti-hsp antibodies with other anti-retinal AAbs may augment pathogenic processes, leading to retinal degeneration.
机译:背景自身免疫性视网膜病(AR)和癌症相关性视网膜病(CAR)与抗视网膜自身抗体(AAb)的多样性有关,但并非所有抗原靶标都已被表征。鉴定新的AAb可能有助于AR的视网膜功能障碍的临床诊断和预后。目的是确定分子量在60-70kDa范围内的经常靶向的视网膜自身抗原。方法采用SDS-PAGE和2D凝胶电泳(2-DE)分离人视网膜蛋白,并用免疫印迹法分别筛选出有或无癌症的AR患者血清。通过电泳分离,使用凝胶内胰蛋白酶消化和质谱分析的考马斯亮蓝染色鉴定蛋白质。通过定量ELISA确定循环血清hsp60和抗hsp60抗体水平。结果回顾性评估819例抗视网膜AAb的患者,发现29%的患者具有60-70-kDa的Aab靶向蛋白。一维凝胶中存在的人类视网膜蛋白的弹枪质谱分析发现该范围内有66种。为了鉴定免疫反应蛋白,我们对2-DE凝胶进行了蛋白质印迹,并显示了一组热休克蛋白(hsps),包括AR患者Abbs经常识别的hsp60和CRMP蛋白,而与癌症状态无关。通过纯化的hsp60和CRMP2蛋白的免疫染色验证了这些结果。 ELISA结果表明,与对照组相比,AR和CAR患者的血清抗hsp60抗体水平显着增加(p?结论在一名患者中,多种抗视网膜抗体经常共存,形成与该综合征相关的抗体阵列Hsps和CRMP-2是AR中新发现的自身抗原,抗hsp抗体与其他抗视网膜AAb的频繁共缔合可能会增强致病过程,导致视网膜变性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号